EP4101445
AMISELIMOD FOR USE IN THE TREATMENT OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.2.2021EP published:
30.4.2025EP application number:
21750441.4
EPO information:
European Patent Register
Max expiry date:
4.2.2041
Title in English:
AMISELIMOD FOR USE IN THE TREATMENT OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROMELanguage of the patent:
English
Timeline
Today
5.2.2021EP application
30.4.2025EP Publication
Owner
Name:
Mitsubishi Tanabe Pharma CorporationAddress:
3-2-10, Dosho-machi, Chuo-ku,, Osaka-shi, Osaka 541-8505, JP
Inventor
Name:
IZAKI, HitoshiAddress:
Osaka-shi, Osaka 541-8505, JP
Name:
HAYASHI, RikakoAddress:
Osaka-shi, Osaka 541-8505, JP
Name:
YANAI, YoshiariAddress:
Osaka-shi, Osaka 541-8505, JP
Priority
Number:
2020019153Date:
6.2.2020Country:
JP
Classification
Categories:
A61K 31/137, A61P 3/02, A61P 21/00, A61P 25/00, A61P 29/02